Skip to main content
OPRX
NASDAQ Trade & Services

OptimizeRx Cuts FY26 Revenue Guidance to $87-$93M Despite Q3 EBITDA Beat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$7.34
Mkt Cap
$138.256M
52W Low
$4.54
52W High
$16.37
52W Position info
62% above low
Off High info
55% below high
Rel. Volume info
3.3× avg
Market data snapshot near publication time

OPRX sits 62% above its 52-week low of $4.54 on elevated volume (3.3× avg).

Summary

OptimizeRx beat on Q3 EBITDA ($6.3M, 29% margin) but cut FY26 revenue guidance to $87-$93M as contracted revenue runs ~20% below last year; 2027 bookings are tracking ~20% ahead.


Key Events · Earnings and Guidance · OPRX

  • FY26 Revenue Guidance Cut

    Full-year 2026 revenue guidance lowered to $87-$93 million; adjusted EBITDA guidance held at $21-$25 million. Contracted revenue for 2026 is tracking approximately 20% below the prior year.

  • Q3 EBITDA Beat, Revenue Down 17%

    Q3 revenue of $21.6 million fell 17% from $26.1 million a year ago, but adjusted EBITDA rose to $6.3 million from $5.1 million — a 29% margin, up more than 900 basis points.

  • Retention Slides to 83%

    Net revenue retention fell to 83% from 121%, driven by a small number of large accounts cutting spend; a previously displaced top-five client resumed spending in Q4 at below-historical levels.

  • Debt Paid Down to $10.4M

    Repaid $9.3 million of debt principal since June 30, 2026, leaving $10.4 million outstanding; management flagged more share repurchase activity in Q4.


Analysis · OPRX · Trade & Services

The Q3 headline numbers beat: revenue of $21.6 million and adjusted EBITDA of $6.3 million, a 29% margin that is up more than 900 basis points year over year even as revenue fell 17%. The problem is the top line. Contracted revenue for 2026 is tracking roughly 20% below last year, so management cut full-year revenue guidance to $87-$93 million while holding adjusted EBITDA at $21-$25 million. Net revenue retention dropped to 83% from 121%, driven by a handful of large accounts rather than broad churn, and one previously displaced top-five client has only just resumed spending in Q4 off non-budgeted dollars. The bull case now rests on 2027: management says contracted revenue for next year is running about 20% ahead as the RFP season starts strong. Balance sheet work is real — $9.3 million of debt principal repaid since June 30 leaves $10.4 million outstanding, with more buyback activity flagged for Q4.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OPRX was trading at $7.34 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $138.3M. The 52-week trading range was $4.54 to $16.37. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OPRX - Latest Insights

OPRX
Nov 13, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.34
Real-time Price: $7.34 info
Change: $0 (0%) info
Market Cap: $138.256M info
OPRX
Nov 11, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $7.34 info
Change: -$1.57 (-18%) info
Market Cap: $138.256M info
OPRX
Aug 12, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.04
Real-time Price: $7.34 info
Change: +$0.300 (+4%) info
Market Cap: $138.256M info
OPRX
Aug 12, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.04
Real-time Price: $7.34 info
Change: +$0.300 (+4%) info
Market Cap: $138.256M info
OPRX
Jun 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.23
Real-time Price: $7.34 info
Change: +$2.11 (+40%) info
Market Cap: $138.256M info